IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hwang, Y.-i.
Right arrow Articles by Purkerson, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hwang, Y.-i.
Right arrow Articles by Purkerson, J. M.

 Previous Article  |  Next Article 

Infection and Immunity, February 2000, p. 511-517, Vol. 68, No. 2
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Acquired, but Not Innate, Immune Responses to Streptococcus pneumoniae Are Compromised by Neutralization of CD40L

Young-il Hwang,1,dagger Moon H. Nahm,1,2,3,4 David E. Briles,5 David Thomas,6,Dagger and Jeffrey M. Purkerson1,*

Departments of Pediatrics,1 Pathology,2 Medicine,3 and Microbiology and Immunology,4 University of Rochester School of Medicine, Rochester, New York; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama5; and Biogen Corp., Cambridge, Massachusetts6

Received 26 July 1999/Returned for modification 14 October 1999/Accepted 3 November 1999

Streptococcus pneumoniae is a significant pathogen of young children and the elderly. Systemic infection by pneumococci is a complex process involving several bacterial and host factors. We have investigated the role of CD40L in host defense against pneumococcal infection. Treatment of mice with MR-1 antibody (anti-CD154/CD40L) markedly reduced antibody responses to the pneumococcal protein PspA, elicited by immunization of purified protein or whole bacteria. In mice immunized with whole bacteria, MR-1 treatment reduced antibody responses to capsular polysaccharides but not cell wall polysaccharides. MR-1 did not suppress antibody responses to isolated capsular polysaccharides but did reduce the production of antibody to a capsular polysaccharide-protein conjugate, indicating that when presented in the context of whole bacteria, the humoral response to capsular polysaccharides is partially T-cell dependent. Despite the reduction of the protective humoral responses to pneumococcal infection, administration of MR-1 had no effect on sepsis, lung infection, or nasal carriage in nonimmune mice inoculated with virulent pneumococci. Thus, short-term neutralization of CD40L does not compromise innate host defenses against pneumococcal invasion.

* Corresponding author. Mailing address: Department of Pediatrics, University of Rochester School of Medicine, 601 Elmwood Ave., Box 777, Rochester, NY 14642. Phone: (716) 273-4697. Fax: (716) 271-7512. E-mail: Jeffrey_Purkerson{at}urmc.rochester.edu.

dagger Present address: Department of Anatomy, College of Medicine, Seoul National University, Seoul 110-799, Korea.

Dagger Present address: Tanox, Inc., Houston, TX 77025.

Infection and Immunity, February 2000, p. 511-517, Vol. 68, No. 2
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2000 by the American Society for Microbiology. All rights reserved.